By comparison, Wegovy (semaglutide) acts on one receptor, while Zepbound (tirzepatide) works on two
2009;4:e4253
GLP-1 Therapy for Inflammation Control: A New Frontier in Health Management The medical community has been exploring innovative approaches to managing chronic diseases and improving overall health
The study was funded by the National Institutes of Health (grants R01GM029090, R01DK138518, R01DK105203, R01DK124265, K99DK141966, K99AR081618, F32HD112123, F32HL170637, F32DK138685 and T32GM142607), the Wu Tsai Human Performance Alliance, the Stanford Diabetes Research Center, the Phil and Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, the Ono Pharma Foundation, the Leducq Foundation, the American Heart Association, and the Stanford University Medical Scientist Training Program.
Frequently asked questions Can I replace all my meals with smoothies on GLP-1 medications